Literature DB >> 18852022

Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.

Marta Imbesi1, Tolga Uz, Radmila Manev, Rajiv P Sharma, Hari Manev.   

Abstract

The tetracycline antibiotic minocycline beneficially affects neuronal functioning and also inhibits the enzyme 5-lipoxygenase (5-LOX). We hypothesized that similar to 5-LOX inhibitors, minocycline may increase phosphorylation and membrane insertion of the glutamate receptor GluR1. The experiments were performed in primary cultures of mouse striatal neurons and in the prefrontal cortex and striatum of minocycline-treated mice. In vitro, low micromolar minocycline concentrations increased GluR1 phosphorylation at Ser845 and Ser831 and increased the surface content of GluR1. Minocycline also increased GluR1 phosphorylation in vivo. Increased GluR1 phosphorylation and minocycline treatment have been associated with antidepressant and memory-enhancing activities. Direct consequences of minocycline-increased GluR1 phosphorylation are yet to be established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852022      PMCID: PMC2604812          DOI: 10.1016/j.neulet.2008.10.006

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

Authors:  J Yrjänheikki; R Keinänen; M Pellikka; T Hökfelt; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons.

Authors:  S Lin; Y Zhang; R Dodel; M R Farlow; S M Paul; Y Du
Journal:  Neurosci Lett       Date:  2001-11-23       Impact factor: 3.046

3.  Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.

Authors:  Michael C Oh; Victor A Derkach; Eric S Guire; Thomas R Soderling
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

4.  Possible antidepressant effect of minocycline.

Authors:  J Levine; A Cholestoy; J Zimmerman
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

5.  Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation.

Authors:  Ying Song; Er-Qing Wei; Wei-Ping Zhang; Qiu-Fu Ge; Jian-Ren Liu; Meng-Ling Wang; Xiao-Jia Huang; Xin Hu; Zhong Chen
Journal:  Brain Res       Date:  2006-03-30       Impact factor: 3.252

6.  Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.

Authors:  Conrad C Alano; Tiina M Kauppinen; Andreu Viader Valls; Raymond A Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

7.  The cell adhesion molecule neuroplastin-65 inhibits hippocampal long-term potentiation via a mitogen-activated protein kinase p38-dependent reduction in surface expression of GluR1-containing glutamate receptors.

Authors:  Ruth M Empson; Lucy E Buckby; Michaela Kraus; Katharine J Bates; Mark R Crompton; Eckart D Gundelfinger; Philip W Beesley
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

8.  Surface expression and metabolic half-life of AMPA receptors in cultured rat cerebellar granule cells.

Authors:  K Archibald; M J Perry; E Molnár; J M Henley
Journal:  Neuropharmacology       Date:  1998 Oct-Nov       Impact factor: 5.250

9.  Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation.

Authors:  Ying Song; Er-Qing Wei; Wei-Ping Zhang; Lei Zhang; Jian-Ren Liu; Zhong Chen
Journal:  Neuroreport       Date:  2004-10-05       Impact factor: 1.837

10.  Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection.

Authors:  Susan C Fagan; David J Edwards; Cesar V Borlongan; Lin Xu; Ankur Arora; Giora Feuerstein; David C Hess
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

View more
  18 in total

1.  Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice.

Authors:  Hu Chen; Hari Manev
Journal:  Neuropharmacology       Date:  2010-09-22       Impact factor: 5.250

Review 2.  Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.

Authors:  David W Volk
Journal:  Neurobiol Dis       Date:  2016-12-19       Impact factor: 5.996

3.  Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures.

Authors:  Agustini Utari; Weerasak Chonchaiya; Susan M Rivera; Andrea Schneider; Randi J Hagerman; Sultana M H Faradz; Iryna M Ethell; Danh V Nguyen
Journal:  Am J Intellect Dev Disabil       Date:  2010-09

Review 4.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors:  Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

5.  Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.

Authors:  Mehmet Sofuoglu; Marc Mooney; Thomas Kosten; Andrew Waters; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2010-09-14       Impact factor: 4.530

6.  Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease.

Authors:  Hu Chen
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-16

Review 7.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

8.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

9.  Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.

Authors:  Claudia Bagni; Flora Tassone; Giovanni Neri; Randi Hagerman
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

10.  Minocycline affects cocaine sensitization in mice.

Authors:  Hu Chen; Tolga Uz; Hari Manev
Journal:  Neurosci Lett       Date:  2009-02-04       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.